We offer less-invasive and non-invasive endoscopes and other medical devices, thereby provide gentle remedies to patients and medical staffs. We are proud of our products that help savinglives and fighting diseases. Our aim is to contribute to society and establish better medical services.

• 
• 

Company Name

FiberTech Co., Ltd.

Locations

Head Office: 3-21 KandaNishiki-cho, Chiyoda-ku, Tokyo 101-0054, Japan

 Phone: +81-3-5259-7600 Facsimile: +81-3-5259-1155

Research Center: Sakura Research Center (Chiba, Japan)

Date Established

October 15, 1998

Capital

100,000,000 JPYen

Shareholders

Fujikura Ltd.　　Suzuki Giken Co.,Ltd.

Member of the Board

Representative Director/President & CEO Takashi Tsumanuma

Representative Director/Executive Vice President Yasuhiro Maekawa

Director Kazuyuki Nihonyanagi

Auditor Tetsu Ito

Advisor

Clinical Advisor Naoki Yahagi PhD, Professor, University of Tokyo

Technical Advisor Kunio Awazu PhD, Professor, Osaka University

Main Business Areas

Development, manufacturing, sale, import, repair, and rental of medical and related devices;
development of medical software.

Membership

Japan Medical Devices Manufacturers Association
Japanese Association of Cardioangioscopy
Japan Society for Endoscopic Surgery
Japan Ophthalmic Instruments Association

Oct/1988

D-Base Japan Co., Ltd was established for development and sale of medical devices applying new technology and medical digital systems

Nov/1998

D-Base Japan launched a portable endoscope co-developed with Sumita Optical Glass, Inc.

Mar/2000

D-Base Japan inherited technology of manufacturing ultra-thin fiberscopes from Medical Science Co., Ltd.

Dec/2000

D-Base Japan relocated its head office to Bunkyo-ku, Tokyo; D-Base Japan was renamed FiberTech Co., Ltd.

Sep/2001

FiberTech was qualified under the Small and Medium Enterprise Creative Endeavors Promotion Law for the development of the video laryngoscope

Oct/2001

FiberTech increased its capital to 25,500,000 JPYen through a third-party allocation of shares

Jan/2002

FiberTech increased its capital to 56,500,000 JPYen through a third-party allocation of shares

Mar/2002

FiberTech launched an angioscope (outside diameter or OD: 0.75mm)

Jul/2002

FiberTech entered into a comprehensive distribution agreement with Vision-Sciences, Inc. (USA), and started distribution of EndoSheath System (sheaths against infection for endoscopes)

Dec/2002

FiberTech increased its capital to 236,000,000 JPYen through a third-party allocation of shares

Jul/2003

FiberTech launched an ultra-thin angioscope (OD: 0.5mm)

Feb/2004

FiberTech was certified under ISO 13485

Apr/2004

FiberTech established Sakura Research Center in Sakura-shi, Chiba

Oct/2004

FiberTech became a wholly owned subsidiary of Internet Research Institute, Inc. (IRI) through a share exchange

Oct/2004

FiberTech relocated its head office to Chiyoda-ku, Tokyo

Oct/2004

FiberTech won the grand prize at “Tokyo Venture Technology Prize 2004”

Nov/2004

FiberTech increased its capital to 336,625,000 JPYen through shareholder allotment

Feb/2005

FiberTech was certified under ISO 9001

Oct/2005

FiberTech increased its capital to 424,125,000 JPYen through shareholder allotment

Dec/2006

FiberTech increased its capital to 489,120,000 JPYen through shareholder allotment

Jul/2007

FiberTech became a group company of Fujikura Ltd. through a share transfer

Nov/2009

Fibertech established its satellite office in Fukuoka, Kyushu

Since the company was established in 1988, FiberTech has put the ultra-thin endoscopes that enable “seeing the invisible with minimal invasion” at the core of its product line and has continuously strived for realization of serving patient-friendly medical devices. And now, we are taking the new step to become the leading “Product and Technology Integrator” in the medical field. Based on deep knowledge and experience acquired through medical device business, we will take advantage of our core micro-technology to realize new applications. We will offer new medical products that meet market needs not only by developing and implementing innovative technologies, but also by revitalizing potential valuable technologies. We believe this will allow us to contribute to the development of next-generation medical technologies and establish our identity in society.

What we are addressing next are the IT-based medical treatment and the comprehensive image processing system. We will create ubiquitous in the medical field by offering solutions such as network interface and IP-based medical devices.

Our activities are not limited to the Japan market. We are making steady steps toward international markets to have our products help patients and medical professionals throughout the world.

Keeping our corporate slogan “C & C (Courage and Challenge)” in mind, we are determined to venture into new fields of business.